Patrick Werbrouck

1.1k total citations
33 papers, 757 citations indexed

About

Patrick Werbrouck is a scholar working on Pulmonary and Respiratory Medicine, Cancer Research and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Patrick Werbrouck has authored 33 papers receiving a total of 757 indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Pulmonary and Respiratory Medicine, 8 papers in Cancer Research and 7 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Patrick Werbrouck's work include Prostate Cancer Treatment and Research (18 papers), Prostate Cancer Diagnosis and Treatment (11 papers) and Cancer, Lipids, and Metabolism (8 papers). Patrick Werbrouck is often cited by papers focused on Prostate Cancer Treatment and Research (18 papers), Prostate Cancer Diagnosis and Treatment (11 papers) and Cancer, Lipids, and Metabolism (8 papers). Patrick Werbrouck collaborates with scholars based in Belgium, United Kingdom and United States. Patrick Werbrouck's co-authors include Hendrik Van Poppel, Dirk De Ridder, Koen Ackaert, G. Pittomvils, Wim Van de Voorde, Raymond Oyen, Hans Pottel, Luc Baert, Ignace Billiet and Mohammad Hirmand and has published in prestigious journals such as Journal of Clinical Oncology, The Lancet Oncology and The Journal of Urology.

In The Last Decade

Patrick Werbrouck

32 papers receiving 741 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Patrick Werbrouck Belgium 13 574 170 130 100 100 33 757
J. Lister United States 14 186 0.3× 252 1.5× 52 0.4× 110 1.1× 85 0.8× 43 744
Dominique Rossi France 14 429 0.7× 209 1.2× 54 0.4× 129 1.3× 64 0.6× 39 690
Irene Resch Austria 13 235 0.4× 212 1.2× 122 0.9× 36 0.4× 33 0.3× 33 634
Han J.A. Mensink Netherlands 10 402 0.7× 156 0.9× 90 0.7× 63 0.6× 155 1.6× 18 647
Hirohiko Nagata Japan 15 291 0.5× 104 0.6× 34 0.3× 75 0.8× 59 0.6× 43 503
M Bolla France 9 435 0.8× 153 0.9× 87 0.7× 48 0.5× 92 0.9× 26 765
Francisco Pina Portugal 12 354 0.6× 86 0.5× 183 1.4× 89 0.9× 18 0.2× 34 680
Christos Alamanis Greece 13 232 0.4× 78 0.5× 57 0.4× 46 0.5× 47 0.5× 24 383
William R. Morgan United States 11 466 0.8× 177 1.0× 56 0.4× 92 0.9× 27 0.3× 15 637
Toyofusa Tobe Japan 14 235 0.4× 191 1.1× 67 0.5× 34 0.3× 36 0.4× 47 469

Countries citing papers authored by Patrick Werbrouck

Since Specialization
Citations

This map shows the geographic impact of Patrick Werbrouck's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Patrick Werbrouck with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Patrick Werbrouck more than expected).

Fields of papers citing papers by Patrick Werbrouck

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Patrick Werbrouck. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Patrick Werbrouck. The network helps show where Patrick Werbrouck may publish in the future.

Co-authorship network of co-authors of Patrick Werbrouck

This figure shows the co-authorship network connecting the top 25 collaborators of Patrick Werbrouck. A scholar is included among the top collaborators of Patrick Werbrouck based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Patrick Werbrouck. Patrick Werbrouck is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bjartell, Anders, Luís Costa, Gero Kramer, et al.. (2022). Real-world Treatment Sequencing in Patients with Metastatic Castration-resistant Prostate Cancer: Results from the Prospective, International, Observational Prostate Cancer Registry. European Urology Open Science. 45. 12–22. 7 indexed citations
2.
Gratzke, Christian, Karim Fizazi, Neal D. Shore, et al.. (2021). 630P Time course profile of adverse events of interest and serious adverse events with darolutamide in the ARAMIS trial. Annals of Oncology. 32. S664–S664.
3.
Lycke, Michelle, Lies Pottel, Hans Pottel, et al.. (2019). Underrepresentation of vulnerable older patients with cancer in phase II and III oncology registration trials: A case-control study. Journal of Geriatric Oncology. 11(2). 320–326. 15 indexed citations
4.
Lycke, Michelle, Lies Pottel, Hans Pottel, et al.. (2019). Subjective, but not objective, cognitive complaints impact long-term quality of life in cancer patients. Journal of Psychosocial Oncology. 37(4). 427–440. 22 indexed citations
5.
6.
Lycke, Michelle, Philip R. Debruyne, Hans Pottel, et al.. (2017). The use of uHear™ to screen for hearing loss in older patients with cancer as part of a comprehensive geriatric assessment. Acta Clinica Belgica. 73(2). 132–138. 15 indexed citations
7.
Tombal, Bertrand, Michael Borre, Per Rathenborg, et al.. (2015). Long-term Efficacy and Safety of Enzalutamide Monotherapy in Hormone-naïve Prostate Cancer: 1- and 2-Year Open-label Follow-up Results. European Urology. 68(5). 787–794. 34 indexed citations
8.
Carducci, Michael A., Anne Armstrong, Роберто Пили, et al.. (2015). 4BA A phase 3, randomized, double-blind, placebo-controlled study of tasquinimod (TASQ) in men with metastatic castrate resistant prostate cancer (mCRPC). European Journal of Cancer. 51. S713–S714. 4 indexed citations
9.
Tombal, Bertrand, Michael Borre, Per Rathenborg, et al.. (2014). Enzalutamide monotherapy in hormone-naive prostate cancer: primary analysis of an open-label, single-arm, phase 2 study. The Lancet Oncology. 15(6). 592–600. 71 indexed citations
10.
Maes, Alex, et al.. (2009). FDG-PET/CT for the Preoperative Lymph Node Staging of Invasive Bladder Cancer. European Urology. 57(4). 641–647. 118 indexed citations
11.
Sergeant, Gregory, et al.. (2003). Recurrent flank pain caused by eosinophilic ureteritis mimicking urinary stone disease: A case report. International Urology and Nephrology. 36(1). 23–25. 7 indexed citations
12.
Billiet, Ignace, et al.. (2003). Cystectomy and Orthotopic Ileal Neobladder Construction. Urologia Internationalis. 71(3). 255–261. 7 indexed citations
13.
Poppel, Hendrik Van, Hans Goethuys, Dirk De Ridder, et al.. (2001). Neoadjuvant Therapy Before Radical Prostatectomy: Impact on Progression Free Survival. 1. 301–307. 6 indexed citations
14.
Baert, Luc, Hans Goethuys, Dirk De Ridder, et al.. (1998). Neoadjuvant treatment before radical prostatectomy decreases the number of positive margins in cT2-cT3 but has no impact on PSA progression or survival in cT2-T3. The Journal of Urology. 159(5). 61–61. 14 indexed citations
15.
Poppel, Hendrik Van, Dirk De Ridder, Abdel‐Aziz A. Elgamal, et al.. (1995). Neoadjuvant Hormonal Therapy Before Radical Prostatectomy Decreases the Number of Positive Surgical Margins in Stage T2 Prostate Cancer. The Journal of Urology. 154(2 Pt 1). 429–434. 93 indexed citations
16.
Ridder, Dirk De, A. Elgamal, Patrick Werbrouck, et al.. (1994). [Hormone therapy before radical prostatectomy. Effects on surgical method and resection margins. Belgian Uro-Oncological Study Group (B.U.O.S.)].. PubMed. 62(1). 61–5. 1 indexed citations
17.
Baert, Luc, Hendrik Van Poppel, & Patrick Werbrouck. (1991). Implantation of the Urethral Stent for Treatment of Complex Urethral Strictures. Urologia Internationalis. 47(1). 35–39. 9 indexed citations
18.
Baert, L., et al.. (1991). Balloon Dilation of the Prostate. Urologia Internationalis. 47(2). 74–76. 3 indexed citations
19.
Werbrouck, Patrick, et al.. (1990). Balloon Dilatation of the External Urethral Sphincter: A Case Study. PubMed. 13(2). 13–14. 1 indexed citations
20.
Werbrouck, Patrick, et al.. (1990). Embryonal Adenoma of the Kidney. European Urology. 17(3). 264–266. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by J. Lister Breakdown of academic impact, for papers by Dominique Rossi Breakdown of academic impact, for papers by Irene Resch Breakdown of academic impact, for papers by Han J.A. Mensink Breakdown of academic impact, for papers by Hirohiko Nagata Breakdown of academic impact, for papers by M Bolla Breakdown of academic impact, for papers by Francisco Pina Breakdown of academic impact, for papers by Christos Alamanis Breakdown of academic impact, for papers by William R. Morgan Breakdown of academic impact, for papers by Toyofusa Tobe
Rankless by CCL
2026